Private company

PRESSURE BIOSCIENCES INC

PRESSURE BIOSCIENCES INC is an American laboratory analytical instruments company.1 It is headquartered in Canton, Massachusetts.1

Last updated Oct 20, 2026.

Overview

  • IndustryLaboratory Analytical Instruments1
  • HeadquartersCanton, Massachusetts1
  • Incorporated inMA2
  • Business address480 Neponset St., Canton, Ma 020212
  • Filer categoryNon-accelerated filer, Smaller reporting company2

See how the biggest companies compare on our leaderboards

14.5 psi) to ultra-high levels (20,000 psi or much greater) and then back to ambient, in a precisely controlled manner.4 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2023

-480.5%Operating margin5
-346.7%Net margin6
14.4%Revenue growth, 20235
-$3.2MFree cash flow5

Where the money goes

Where each dollar of revenue went, fiscal 2023

  • Cost of revenue6¢$1.2M
  • Research and development8¢$1.4M
  • Interest86¢$15.6M

Out of $2.0M in revenue.56 The company lost money this year.

Financial statements

Revenue78910115$2.0M in 2023−12% since 2017
0$1.0M$2.0M$3.0M2017: $2.2M$2.2M20172018: $2.5M$2.5M2018+10%2019: $1.8M$1.8M2019−26%2020: $1.2M$1.2M2020−33%2021: $2.0M$2.0M2021+64%2022: $1.7M$1.7M2022−14%2023: $2.0M$2.0M2023+14%
Operating income5891011-$9.5M in 2023
-$50.0M0$50.0M$100.0M2017: $91.0M$91.0M20172018: -$4.5M-$4.5M20182019: -$5.8M-$5.8M2019+30%2020: -$4.6M-$4.6M2020−21%2021: -$4.2M-$4.2M2021−9%2022: -$4.9M-$4.9M2022+17%2023: -$9.5M-$9.5M2023+94%
Net income789101156-$6.9M in 2023−36% since 2017
-$30.0M-$20.0M-$10.0M02017: -$10.7M-$10.7M20172018: -$9.7M-$9.7M2018−9%2019: -$11.7M-$11.7M2019+20%2020: -$16.0M-$16.0M2020+37%2021: -$20.2M-$20.2M2021+26%2022: -$16.1M-$16.1M2022−20%2023: -$6.9M-$6.9M2023−57%
Fiscal year2017201820192020202120222023
Revenue$2.2M7$2.5M8$1.8M9$1.2M10$2.0M11$1.7M5$2.0M5
Cost of revenue$1.3M7$1.3M8$1.2M9$582.9K10$942.4K11$2.0M5$1.2M5
Research and development$988.6K7$1.2M8$1.2M9$1.1M10$1.1M11$969.5K5$1.4M5
Operating expenses$6.2M11$6.6M5$11.5M5
Operating income$91.0M5-$4.5M8-$5.8M9-$4.6M10-$4.2M11-$4.9M5-$9.5M5
Interest$6.1M7$4.2M8$5.3M9$8.3M10$14.5M11$10.4M5$15.6M5
Income tax-$217.2K9
Net income-$10.7M7-$9.7M8-$11.7M9-$16.0M10-$20.2M11-$16.1M5-$6.9M6
Earnings per share-$3.4211-$1.615-$1.515
Earnings per share (diluted)-$1.615-$1.515
Shares (weighted, basic)6.6M shares1111.1M shares523.3M shares5
Shares (weighted, diluted)11.1M shares523.3M shares5

Compare PRESSURE BIOSCIENCES INC with another company

Corporate structure

PRESSURE BIOSCIENCES INC sits at the top of its group. 4 entities, 2 countries on record. Switch between the flow chart and the network, and select any entity to see its details.

  • PRESSURE BIOSCIENCES INC Canton, Massachusetts
    • Agrochem, Inc. Subsidiary · Massachusetts, United States
    • BioSciences Europe Subsidiary · Poland
    • BioSeq, Inc. Subsidiary · Massachusetts, United States

Built from subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What PRESSURE BIOSCIENCES INC reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Machinery and equipment$381.6K5 Dec 31, 2023$374.1K5 Dec 31, 2022+2.0%
Furniture and fixtures$195.0K5 Dec 31, 2023$195.0K5 Dec 31, 20220%
Leasehold improvements$25.2K5 Dec 31, 2023$25.2K5 Dec 31, 20220%
Property and equipment, before depreciation$655.0K5 Dec 31, 2023$647.5K5 Dec 31, 2022+1.2%
Accumulated depreciation$570.0K5 Dec 31, 2023$544.1K5 Dec 31, 2022+4.8%
Property and equipment, net$84.9K5 Dec 31, 2023$103.4K5 Dec 31, 2022−17.8%
Operating-lease assets (leased space)$142.8K5 Dec 31, 2023$282.1K5 Dec 31, 2022−49.4%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$81.3K5 Dec 31, 2023$3.9K5 Dec 31, 2022+2002.9%
Stakes in other companies (equity method)$61.9K5 Dec 31, 2023$63.6K5 Dec 31, 2022−2.8%

Intangibles and goodwill

ItemLatestA year beforeChange
Accumulated amortization$750.0K5 Dec 31, 2023$432.7K5 Dec 31, 2022+73.3%
Patents, net$750.0K5 Dec 31, 2023$750.0K5 Dec 31, 20220%

Inventory

ItemLatestA year beforeChange
Inventory, total$304.9K5 Dec 31, 2023$686.4K5 Dec 31, 2022−55.6%
Raw materials$64.0K5 Dec 31, 2023$188.6K5 Dec 31, 2022−66.1%
Finished goods$1.3M5 Dec 31, 2023$1.5M5 Dec 31, 2022−14.7%

Leadership

Who has led PRESSURE BIOSCIENCES INC, and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Richard T. Schumacher2006–2024

President

  1. Richard T. Schumacher2006–2024

Chief financial officer

  1. Edward H. Myles2006–2008
  2. Conrad F. Mir2012
  3. Richard Thomley2013–2014
  4. Joseph Luis Damasio Jr.2017–2018
  5. Daniel Joseph Shea2019
2010201520202025
Board members and other officers (17)

Subsidiaries and ownership

Subsidiaries (Exhibit 21)

  • Agrochem, Inc. Massachusetts3
  • BioSciences Europe Poland3
  • BioSeq, Inc. Massachusetts3

The subsidiaries the company lists in Exhibit 21 of its annual report, as filed.

Former names

  • BOSTON BIOMEDICA INCOct 25, 1996 to Sep 2, 20042

Timeline

  1. Jul 17, 20248-K Other events35
  2. Jul 3, 20248-K Executive or director change36
  3. Apr 22, 20248-K Shareholder vote37
  4. Jan 25, 20248-K Entered a material agreement; Other events38
  5. Oct 24, 20238-K Executive or director change39
  6. May 5, 20238-K Bylaws or fiscal year changed40
  7. Mar 6, 20238-K Entered a material agreement; Unregistered sale of shares41
  8. Jan 5, 20238-K Shareholder vote42
  9. Jan 4, 20228-K Shareholder vote43
  10. Apr 3, 2006New chief executive Richard T. Schumacher becomes CEO13

Filings

116 filings to the SEC since October 2021: 3 annual reports, 9 quarterly reports, 9 major events, 82 insider forms, 13 other. The latest 20:

  1. Feb 7, 202510-Q EDGAR
  2. Sep 30, 20244 EDGAR
  3. Sep 30, 20244 EDGAR
  4. Sep 30, 20244 EDGAR
  5. Sep 30, 20244 EDGAR
  6. Sep 6, 202410-Q EDGAR
  7. Aug 19, 2024NT 10-Q EDGAR
  8. Jul 17, 20248-K EDGAR
  9. Jul 3, 20248-K EDGAR
  10. Jun 7, 202410-K EDGAR
  11. May 17, 2024NT 10-Q EDGAR
  12. Apr 22, 20248-K EDGAR
  13. Apr 1, 2024NT 10-K EDGAR
  14. Mar 28, 20244 EDGAR
  15. Mar 28, 20244 EDGAR
  16. Mar 28, 20244 EDGAR
  17. Mar 28, 20244 EDGAR
  18. Mar 28, 20244 EDGAR
  19. Mar 28, 20244 EDGAR
  20. Feb 27, 2024DEF 14A EDGAR

The 116 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

SEC filer profile

How PRESSURE BIOSCIENCES INC is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARPRESSURE BIOSCIENCES INC1
  • CIK0000830656
  • Employer ID (EIN)04-26528261
  • Filer statusNon-accelerated filer<br>smaller reporting company1
  • Incorporated inMassachusetts1
  • Fiscal year endsDecember 311
  • Industry code (SIC)3826 Laboratory Analytical Instruments1
  • SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance1
  • Business address480 Neponset St., Canton, MA 020211
  • Phone50823018281
  • Shares outstanding40,967,084 as of Jan 31, 202512
  • Public float$8.0M as of Dec 31, 20235
  • On EDGAR sinceAug 23, 19961
  • Filings969 in all: 4 (467), 8-K (153), 10-Q (75), 10-K (25), 3 (24), DEF 14A (24), NT 10-Q (16), SC 13G (12)1
    All 56 form types

    FWP (11), SC 13G/A (11), NT 10-K (10), S-1/A (10), UPLOAD (10), 10QSB (9), D (8), CORRESP (7), PRE 14A (6), S-8 (6), SC 13D (6), S-3/A (5), SC 13D/A (5), 10-K/A (4), 10-Q/A (4), PRER14A (4), S-3 (4), SC 13E3/A (4), SC TO-I/A (4), 10KSB (3), 4/A (3), DEFS14A (3), DFAN14A (3), S-1 (3), 424B2 (2), 424B5 (2), 8-A12G (2), EFFECT (2), RW (2), SC TO-C (2), 10KSB/A (1), 10QSB/A (1), 25-NSE (1), 424B3 (1), 424B4 (1), 8-A12B (1), 8-A12G/A (1), 8-K/A (1), CERTNAS (1), D/A (1), DEFA14A (1), DEFM14A (1), DEFR14A (1), NTN 10K (1), PREM14A (1), REGDEX (1), SC 13E3 (1), SC TO-I (1)

  • Latest filingsAnnual report (10-K) Jun 7, 2024
    Quarterly report (10-Q) Feb 7, 2025
    Proxy statement (DEF 14A) Feb 27, 2024
    Latest 8-K (8-K) Jul 17, 2024

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
    SEC EDGAROther events
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43